14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $0.0060 $169.56 Friday, 27th May 2022 ANTH stock ended at $0.000001. During the day the stock fluctuated 0% from a day low at $0.000001 to a day high of $0.000001.
90 days $113.65 $133.77
52 weeks $171.20 $133.77

Historical Anthera Pharmaceuticals prices

Date Open High Low Close Volume
Jun 15, 2016 $24.64 $24.64 $24.64 $24.64 87 163
Jun 14, 2016 $25.52 $25.52 $25.52 $25.52 96 296
Jun 13, 2016 $27.28 $27.28 $27.28 $27.28 56 094
Jun 10, 2016 $27.20 $27.20 $27.20 $27.20 69 757
Jun 09, 2016 $28.16 $28.16 $28.16 $28.16 71 444
Jun 08, 2016 $29.84 $29.84 $29.84 $29.84 59 550
Jun 07, 2016 $30.56 $30.56 $30.56 $30.56 46 336
Jun 06, 2016 $30.40 $30.40 $30.40 $30.40 40 352
Jun 03, 2016 $29.92 $29.92 $29.92 $29.92 46 400
Jun 02, 2016 $30.48 $30.48 $30.48 $30.48 71 961
Jun 01, 2016 $28.96 $28.96 $28.96 $28.96 57 033
May 31, 2016 $29.44 $29.44 $29.44 $29.44 57 258
May 27, 2016 $27.92 $27.92 $27.92 $27.92 46 448
May 26, 2016 $28.32 $28.32 $28.32 $28.32 56 354
May 25, 2016 $29.20 $29.20 $29.20 $29.20 58 557
May 24, 2016 $28.64 $28.64 $28.64 $28.64 38 132
May 23, 2016 $28.80 $28.80 $28.80 $28.80 48 132
May 20, 2016 $28.80 $28.80 $28.80 $28.80 49 414
May 19, 2016 $26.88 $26.88 $26.88 $26.88 39 500
May 18, 2016 $26.88 $26.88 $26.88 $26.88 51 010
May 17, 2016 $27.20 $27.20 $27.20 $27.20 74 575
May 16, 2016 $27.52 $27.52 $27.52 $27.52 50 348
May 13, 2016 $26.00 $26.00 $26.00 $26.00 32 707
May 12, 2016 $25.12 $25.12 $25.12 $25.12 56 415
May 11, 2016 $26.88 $26.88 $26.88 $26.88 55 063
Click to get the best stock tips daily for free!

About Anthera Pharmaceuticals

Anthera Pharmaceuticals Anthera Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of medicines for patients with unmet medical needs. It develops Sollpura, a non-porcine investigational pancreatic enzyme replacement therapy that is in Phase III clinical trial for the treatment of patients with exocrine pancreatic insufficiency; and Blisibimod, which is in Phase II clinical trial for the treatment of B-cell mediated auto... ANTH Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT